Yasuaki Anami[Author] - Search Results

Year	Number of Results
2014	2
2015	1
2016	3
2017	3
2018	2
2019	1
2020	3
2021	2
2022	4
2024	1

1

Exploring the next generation of antibody-drug conjugates.

Tsuchikama K, Anami Y, Ha SYY, Yamazaki CM. Tsuchikama K, et al. Among authors: anami y. Nat Rev Clin Oncol. 2024 Mar;21(3):203-223. doi: 10.1038/s41571-023-00850-2. Epub 2024 Jan 8. Nat Rev Clin Oncol. 2024. PMID: 38191923 Review.

2

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance.

Yamazaki CM, Yamaguchi A, Anami Y, Xiong W, Otani Y, Lee J, Ueno NT, Zhang N, An Z, Tsuchikama K. Yamazaki CM, et al. Among authors: anami y. Nat Commun. 2021 Jun 10;12(1):3528. doi: 10.1038/s41467-021-23793-7. Nat Commun. 2021. PMID: 34112795 Free PMC article.

3

An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.

Ha SYY, Anami Y, Yamazaki CM, Xiong W, Haase CM, Olson SD, Lee J, Ueno NT, Zhang N, An Z, Tsuchikama K. Ha SYY, et al. Among authors: anami y. Mol Cancer Ther. 2022 Sep 6;21(9):1449-1461. doi: 10.1158/1535-7163.MCT-22-0362. Mol Cancer Ther. 2022. PMID: 35793453 Free PMC article.

4

Transglutaminase-Mediated Conjugations.

Anami Y, Tsuchikama K. Anami Y, et al. Methods Mol Biol. 2020;2078:71-82. doi: 10.1007/978-1-4939-9929-3_5. Methods Mol Biol. 2020. PMID: 31643050

5

Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.

Anami Y, Xiong W, Yamaguchi A, Yamazaki CM, Zhang N, An Z, Tsuchikama K. Anami Y, et al. RSC Adv. 2022 Jan 26;12(6):3359-3364. doi: 10.1039/d1ra08131d. eCollection 2022 Jan 24. RSC Adv. 2022. PMID: 35425350 Free PMC article.

6

Helix12-Stabilization Antagonist of Vitamin D Receptor.

Kato A, Itoh T, Anami Y, Egawa D, Yamamoto K. Kato A, et al. Among authors: anami y. Bioconjug Chem. 2016 Jul 20;27(7):1750-61. doi: 10.1021/acs.bioconjchem.6b00246. Epub 2016 Jun 27. Bioconjug Chem. 2016. PMID: 27294600

7

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors.

Anami Y, Otani Y, Xiong W, Ha SYY, Yamaguchi A, Rivera-Caraballo KA, Zhang N, An Z, Kaur B, Tsuchikama K. Anami Y, et al. Cell Rep. 2022 May 24;39(8):110839. doi: 10.1016/j.celrep.2022.110839. Cell Rep. 2022. PMID: 35613589 Free PMC article.

8

Total Synthesis of the Monomeric Unit of Lomaiviticin A.

Nicolaou KC, Chen Q, Li R, Anami Y, Tsuchikama K. Nicolaou KC, et al. Among authors: anami y. J Am Chem Soc. 2020 Nov 25;142(47):20201-20207. doi: 10.1021/jacs.0c10660. Epub 2020 Nov 13. J Am Chem Soc. 2020. PMID: 33186022

9

Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model.

Zhao P, Anami Y, Gao P, Fan X, Li L, Tsuchikama K, Zhang N, An Z. Zhao P, et al. Among authors: anami y. MAbs. 2022 Jan-Dec;14(1):2057269. doi: 10.1080/19420862.2022.2057269. MAbs. 2022. PMID: 35388745 Free PMC article.

10

LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.

Anami Y, Deng M, Gui X, Yamaguchi A, Yamazaki CM, Zhang N, Zhang CC, An Z, Tsuchikama K. Anami Y, et al. Mol Cancer Ther. 2020 Nov;19(11):2330-2339. doi: 10.1158/1535-7163.MCT-20-0407. Epub 2020 Sep 2. Mol Cancer Ther. 2020. PMID: 32879051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year